Autonomix Medical Inc.

AMIX | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.05

-$0.16 (-3.80%)

At close: Sep 21, 2026, 4:00 PM ET

$4.06

+$0.01 (+0.27%)

Pre-market: Sep 22, 2026, 8:16 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.2M

Enterprise Value $-1.26M

Beta -1.30

Average Volume 3.14M

Shares Outstanding (Diluted) 543.69K

Shares Change YoY 267.69%

Institutional Ownership 3.14%

Exchange NASDAQ

ISIN US05330T3041

Price Performance

Price Change 1M -22.9%

Price Change 3M -46.3%

Price Change 6M -55.5%

Price Change YTD -64.1%

Price Change 1Y -82.6%

Price Change 3Y -99.8%

Price Change 5Y -99.8%

1M CAGR (ann.) -59.7%

1Y CAGR (ann.) -81.6%

5Y CAGR (ann.) N/A

All-Time CAGR -90.6%

Valuation

PE Ratio -0.09

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.01

PS Ratio N/A

Forward PS N/A

PB Ratio 0.70

P/FCF Ratio -0.18

P/Adj. FCF Ratio -0.18

P/OCF Ratio -0.18

EV/Sales N/A

EV/EBIT 0.08

EV/EBITDA 0.08

EV/FCF 0.10

Earnings Yield -1145.4%

FCF Yield -549.4%

Adj. FCF Yield -549.7%

Financial Health

Net Cash $3.46M

Total Debt $0

Cash & Short-Term Investments $3.46M

Total Assets $3.98M

Current Ratio 4.85

Quick Ratio 4.85

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -35.45

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) 0.0%

Returns

Return on Assets -404.7%

Return on Equity -267.7%

Return on Invested Capital -518.1%

Return on Capital Employed -518.1%

Return on Tangible Assets -404.7%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 40.2%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -20.2%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y 20.8%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$6.20

EPS Growth Est (next Q) -78.6%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $2

Price Target Upside -50.6%

Cash Flow

Operating Cash Flow $-12.07M

Free Cash Flow $-12.08M

Adj. Free Cash Flow $-12.09M

FCF Per Share -$22.22

OCF Per Share -$22.21

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-3K

Operating Income $-16.38M

EBITDA $-16.21M

Net Income $-16.11M

EPS (Diluted) -$46.39

Revenue / Employee N/A

Profit / Employee $-1.61M

Employees 10